Literature DB >> 15568818

Mechanism of inhibition of human KSP by monastrol: insights from kinetic analysis and the effect of ionic strength on KSP inhibition.

Lusong Luo1, Jeffrey D Carson, Dashyant Dhanak, Jeffrey R Jackson, Pearl S Huang, Yan Lee, Roman Sakowicz, Robert A Copeland.   

Abstract

Kinesin motor proteins utilize the energy from ATP hydrolysis to transport cellular cargo along microtubules. Kinesins that play essential roles in the mechanics of mitosis are attractive targets for novel antimitotic cancer therapies. Monastrol, a cell-permeable inhibitor that specifically inhibits the kinesin Eg5, the Xenopus laevis homologue of human KSP, can cause mitotic arrest and monopolar spindle formation. In this study, we show that the extent of monastrol inhibition of KSP microtubule-stimulated ATP hydrolysis is highly dependent upon ionic strength. Detailed kinetic analysis of KSP inhibition by monastrol in the presence and absence of microtubules suggests that monastrol binds to the KSP-ADP complex, forming a KSP-ADP-monastrol ternary complex, which cannot bind to microtubules productively and cannot undergo further ATP-driven conformational changes.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15568818     DOI: 10.1021/bi048282t

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  13 in total

1.  Niche-Based Screening in Multiple Myeloma Identifies a Kinesin-5 Inhibitor with Improved Selectivity over Hematopoietic Progenitors.

Authors:  Shrikanta Chattopadhyay; Alison L Stewart; Siddhartha Mukherjee; Cherrie Huang; Kimberly A Hartwell; Peter G Miller; Radhika Subramanian; Leigh C Carmody; Rushdia Z Yusuf; David B Sykes; Joshiawa Paulk; Amedeo Vetere; Sonia Vallet; Loredana Santo; Diana D Cirstea; Teru Hideshima; Vlado Dančík; Max M Majireck; Mahmud M Hussain; Shambhavi Singh; Ryan Quiroz; Jonathan Iaconelli; Rakesh Karmacharya; Nicola J Tolliday; Paul A Clemons; Malcolm A S Moore; Andrew M Stern; Alykhan F Shamji; Benjamin L Ebert; Todd R Golub; Noopur S Raje; David T Scadden; Stuart L Schreiber
Journal:  Cell Rep       Date:  2015-02-05       Impact factor: 9.423

2.  Loop 5-directed compounds inhibit chimeric kinesin-5 motors: implications for conserved allosteric mechanisms.

Authors:  Liqiong Liu; Sreeja Parameswaran; Jing Liu; Sunyoung Kim; Edward J Wojcik
Journal:  J Biol Chem       Date:  2010-12-02       Impact factor: 5.157

3.  Initial testing (stage 1) of the kinesin spindle protein inhibitor ispinesib by the pediatric preclinical testing program.

Authors:  Hernan Carol; Richard Lock; Peter J Houghton; Christopher L Morton; E Anders Kolb; Richard Gorlick; C Patrick Reynolds; John M Maris; Stephen T Keir; Catherine A Billups; Malcolm A Smith
Journal:  Pediatr Blood Cancer       Date:  2009-12-15       Impact factor: 3.167

4.  Loop L5 acts as a conformational latch in the mitotic kinesin Eg5.

Authors:  William M Behnke-Parks; Jeremie Vendome; Barry Honig; Zoltan Maliga; Carolyn Moores; Steven S Rosenfeld
Journal:  J Biol Chem       Date:  2010-12-09       Impact factor: 5.157

5.  Triphenylbutanamines: kinesin spindle protein inhibitors with in vivo antitumor activity.

Authors:  Fang Wang; James A D Good; Oliver Rath; Hung Yi Kristal Kaan; Oliver B Sutcliffe; Simon P Mackay; Frank Kozielski
Journal:  J Med Chem       Date:  2012-02-13       Impact factor: 7.446

6.  Ethyl 1,6-dimethyl-2-oxo-4-(quinolin-4-yl)-1,2,3,4-tetra-hydro-pyrimidine-5-carboxyl-ate.

Authors:  Roman I Zubatyuk; Oleg V Shishkin; Heiko Ihmels; Iryna A Lebedyeva; Mykhaylo V Povstyanoy
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2010-06-23

7.  Dual pathway spindle assembly increases both the speed and the fidelity of mitosis.

Authors:  Kuniyoshi Kaseda; Andrew D McAinsh; Robert A Cross
Journal:  Biol Open       Date:  2011-10-24       Impact factor: 2.422

8.  Effective killing of the human pathogen Candida albicans by a specific inhibitor of non-essential mitotic kinesin Kip1p.

Authors:  Penelope R Chua; David M Roof; Yan Lee; Roman Sakowicz; David Clarke; Dan Pierce; Thoryn Stephens; Matthew Hamilton; Brad Morgan; David Morgans; Takashi Nakai; Adam Tomasi; Mary E Maxon
Journal:  Mol Microbiol       Date:  2007-06-15       Impact factor: 3.501

9.  Optimized S-trityl-L-cysteine-based inhibitors of kinesin spindle protein with potent in vivo antitumor activity in lung cancer xenograft models.

Authors:  James A D Good; Fang Wang; Oliver Rath; Hung Yi Kristal Kaan; Sandeep K Talapatra; Dawid Podgórski; Simon P MacKay; Frank Kozielski
Journal:  J Med Chem       Date:  2013-02-27       Impact factor: 7.446

10.  Dihydropyrimidine-2-thiones as Eg5 inhibitors and L-type calcium channel blockers: potential antitumour dual agents.

Authors:  Elena González-Hernández; Rubén Aparicio; Mercedes Garayoa; M José Montero; M Ángeles Sevilla; Concepción Pérez-Melero
Journal:  Medchemcomm       Date:  2019-07-04       Impact factor: 3.597

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.